China Medical System Holdings Ltd
F:2M7C
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
China Medical System Holdings Ltd
F:2M7C
|
CN |
|
Man Wah Holdings Ltd
F:AAM
|
HK |
|
Thule Group AB
F:TU0
|
SE |
|
Community Healthcare Trust Inc
F:4U9
|
US |
|
T
|
Teixeira Duarte SA
XMUN:TXC2
|
PT |
Wall St Price Targets
2M7C Price Targets Summary
China Medical System Holdings Ltd
According to Wall Street analysts, the average 1-year price target for 2M7C is 2.46 EUR with a low forecast of 2.08 EUR and a high forecast of 2.83 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 2M7C's stock price target?
Price Target
2.46
EUR
According to Wall Street analysts, the average 1-year price target for 2M7C is 2.46 EUR with a low forecast of 2.08 EUR and a high forecast of 2.83 EUR.
What is the Revenue forecast for China Medical System Holdings Ltd?
Projected CAGR
21%
Over the last 14 years, the compound annual growth rate for Revenue has been 14%. The projected CAGR for the next 3 years is 21%.
What is the Gross Profit forecast for China Medical System Holdings Ltd?
Projected CAGR
18%
Over the last 14 years, the compound annual growth rate for Gross Profit has been 16%. The projected CAGR for the next 3 years is 18%.
What is the Operating Income forecast for China Medical System Holdings Ltd?
Projected CAGR
28%
Over the last 14 years, the compound annual growth rate for Operating Income has been 10%. The projected CAGR for the next 3 years is 28%.
What is the Pre-Tax Income forecast for China Medical System Holdings Ltd?
Projected CAGR
22%
Over the last 14 years, the compound annual growth rate for Pre-Tax Income has been 12%. The projected CAGR for the next 3 years is 22%.
What is the Net Income forecast for China Medical System Holdings Ltd?
Projected CAGR
27%
Over the last 14 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 3 years is 27%.